Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Dogwood Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +2 vs. Q3 2022
- Shares held
- 1.30M
- +14.4K (+1.1%) vs. Q3 2022
- Total value
- $307.7K
- −$178.0K (−36.7%) vs. Q3 2022
- New holders
- 4
- 9 more added
- Sold out
- 2
- 7 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 235,400 | $56.0K | 0.00% | +58,800+33.3% | Added |
| Walleye Capital LLC | 164,314 | $38.8K | 0.00% | +14,314+9.5% | Added |
| Warberg Asset Management LLC | 160,000 | $37.8K | 0.01% | −40,000−20.0% | Reduced |
| Vanguard Group Inc | 148,651 | $35.1K | 0.00% | −93,015−38.5% | Reduced |
| Envestnet Asset Management Inc | 109,196 | $25.8K | 0.00% | +93,050+576.3% | Added |
| PVG Asset Management Corp | 80,590 | $19.0K | 0.08% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 60,286 | $14.0K | 0.00% | 00.0% | Unchanged |
| Koshinski Asset Management, Inc. | 40,924 | $9.66K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 39,250 | $9.26K | 0.00% | +896+2.3% | Added |
| Ergoteles LLC | 32,309 | $7.63K | 0.00% | +32,309 | New |
| Raymond James & Associates | 30,000 | $7.08K | 0.00% | −5,000−14.3% | Reduced |
| Advisor Group Holdings, Inc. | 27,829 | $7.00K | 0.00% | +19,208+222.8% | Added |
| Regions Financial Corp | 20,072 | $5.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,541 | $4.85K | 0.00% | +9,233+81.7% | Added |
| Cetera Advisors LLC | 20,524 | $4.84K | 0.00% | −23,420−53.3% | Reduced |
| Group One Trading, L.P. | 20,022 | $4.72K | 0.00% | +8,500+73.8% | Added |
| Virtu Financial LLC | 16,780 | $4.00K | 0.00% | −30,985−64.9% | Reduced |
| Cetera Investment Advisers | 16,148 | $3.81K | 0.00% | +16,148 | New |
| Northern Trust Corp | 15,836 | $3.74K | 0.00% | 00.0% | Unchanged |
| Cetera Advisor Networks LLC | 14,966 | $3.53K | 0.00% | +14,966 | New |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $2.60K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 10,628 | $2.51K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 4,798 | $1.00K | 0.00% | −16,086−77.0% | Reduced |
| Wells Fargo & Company | 117 | $28 | 0.00% | +69+143.8% | Added |
| Morgan Stanley | 11 | $3 | 0.00% | −4,627−99.8% | Reduced |
| Citadel Advisors LLC | 5 | $1 | 0.00% | +5 | New |
| Cutler Group LP | 2,300 | $0 | 0.00% | +1,100+91.7% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −41,041−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −33−100.0% | Sold out |